Breaking the #ACCESS barriers to allo-HCT Sarah Wall, MD MPH getting the meeting started on my favorite topic! 💪🏼NMDP

ACCESS Initiative leader Jeff Auletta & Stella M. Davies discuss the status of the ACCESS Initiative, including ongoing projects and future objectives. Learn more about the ASTCT & NMDP #ACCESSInitiative: astct.org/Advocacy/ACCES…

Our analysis of intensive chemo (IC) in CBF-AML (200 pt) is out in eJHaem Journal! Kudos to lead author Alexandra Rojek We found: -similar EFS/OS betw IC + GO & IC alone -longer 3y EFS w/ IC + KIT inhibitor (85%) we eagerly await NCT02013648 results! onlinelibrary.wiley.com/doi/10.1002/jh…

Study: In patients with diffuse large B-cell non-Hodgkin lymphoma, CAR-T toxicities CRS and ICAN are extremely rare after two weeks. This supports a shorter, more flexible monitoring period. Read more: ow.ly/olkb50SJknc Blood Advances Nausheen Ahmed MD KU Cancer Center

Thank you to everyone who joined ASTCT & NMDP in DC for the 3rd annual ACCESS Initiative Workshop! #ACCESSInitiative is our joint effort to address access & outcome disparities in the #HCT & cell therapy ecosystem. Learn more: ow.ly/8Pka50SItqC

👉👉👉Delighted to present my all today at MD Anderson Cancer Center Dept of Leukemia Wednesday Noon Grand Rounds on #JAKi combinations in Myelofibrosis: Past, Present,Future. #MPNSM Peter Loffelhardt Sanam Loghavi, MD صنم لغوی 🔬🧬 acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… ascopubs.org/doi/10.1200/JC… ncbi.nlm.nih.gov/pmc/articles/P…

Optimizing the Post-CAR T Monitoring Period Al-Ola A Abdallah MD (USMIRC) Nausheen Ahmed MD ASH USMIRC News oncodaily.com/111447.html #Cancer #OncoDaily #Oncology #UniversityOfKansasMedicalCenter #CancerCare

IgG replacement in multiple myeloma | Blood Cancer Journal ⁦Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽⁩ nature.com/articles/s4140…

5year PFS of 29% is sobering … lots of important work needed ! #CART #Tcell Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium | Journal of Clinical Oncology ascopubs.org/doi/abs/10.120…

#CART ID practices effort — kudos to Zainab Shahid MD, FACP, FIDSA 🇺🇸🇵🇰 for leading this and rescuing this effort from ASTCT , and to all contributors for the critical contributions Martina Pennisi Joshua Hill, MD Swetha Kambhampati Lekha Mikkilineni and others

FDA Approves Axatilimab for Patients With Chronic GVHD targetedonc.com/view/fda-appro…

Growing up/living as a woman in India is an experience, not sure anyone needs to have … one of the reasons I left … but now feel the one reason I should have stayed ….

Kicking off the MPN Workshop of the Carolinas with esteemed hosts and organizers Ruben A. Mesa, MD & Naveen Pemmaraju, MD! #mpnsm

So grateful for our amazing #MPNworkshopNC co-chairs for helping us put together an incredible meeting in amazing #AshevilleNC Naveen Pemmaraju, MD Lindsay Rein Brandi Reeves Alexander Coltoff, MD #RupaliBhave #MikeGrunwald Levine Cancer Wake Forest Baptist - Comprehensive Cancer Center Duke Cancer UNC Lineberger MUSC Hollings Cancer Center

👏What a start to our final Day - Day 3 - of our #MPNWorkshopNC24 ! Focus on alloSCT in MF & Rare & Overlap Disease | Amazing session moderated by Dr Jeanne M Palmer & Dr Zohra Nooruddin | Dr Popat Dr Tania Jain Dr Mrinal Patnaik Dr Jason Gotlib | #MPNSM | Ruben A. Mesa, MD Ross Levine Lab

Phenomenal #MPNworkshopNC A special huge thanks to Ruben A. Mesa, MD & Naveen Pemmaraju, MD for #BMTsm & #MDSMPN sessions - much needed. huge congrats to the entire team for a successful conference at a beautiful location Lindsay Rein Brandi Reeves Mike Grunwald, Rupali Bhave, Alex Coltoff #mpnsm

Successful pregnancies after alloHCT. Key factors for increasing the chance of motherhood: younger age at HCT, non-malignant disease, no TBI or dose <8Gy and RIC/NMA conditioning #bmtsm Katja Sockel Blood Journal ashpublications.org/blood/article/…

How does Dr. Kremyanskaya bridge the gap between lab discoveries and real-world applications? The MD, PhD’s combo of empathy and curiosity might be her secret weapon against rare blood cancers. mpnrf.info/4g8GDjG

Meet @theIACH Faculty during IACH Meeting 2024 iachlive.cme-congresses.com/faculty/

Sarah Wall, MD MPH is the new Ohio State Hematology #bmt and #cellular therapy clinical operations director! Discussing infrastructure, resources, supportive care, team + much more to operate a successful and sustainable program. Translation = LOTs of meetings !! Marcos de Lima